Trials / Conditions / Adult Mixed Cellularity Hodgkin Lymphoma

Adult Mixed Cellularity Hodgkin Lymphoma

9 registered clinical trials studyying Adult Mixed Cellularity Hodgkin Lymphoma.

Status	Trial	Sponsor	Phase
Completed	CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lym NCT02168140	Wake Forest University Health Sciences	Phase 1
Completed	Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma NCT01535924	Beth Christian	Phase 1 / Phase 2
Unknown	Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II NCT01476410	Northwestern University	Phase 2
Completed	A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma NCT01460940	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Re NCT00381940	National Cancer Institute (NCI)	Phase 2
Completed	SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma NCT00337194	National Cancer Institute (NCI)	Phase 2
Terminated	Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma NCT00112723	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma NCT00132028	National Cancer Institute (NCI)	Phase 2
Completed	Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma NCT00082966	National Cancer Institute (NCI)	Phase 2